Treatment of pregnant women with a diagnosis of inflammatory bowel disease
Authors:
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Pharmacology and Therapeutics
- Vol. 7 (4) , 490-502
Abstract
Treatment of pregnant women with a diagnosis of inflammatory bowel diseaseKeywords
This publication has 118 references indexed in Scilit:
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2013
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal ExposureClinical Gastroenterology and Hepatology, 2013
- Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006Alimentary Pharmacology & Therapeutics, 2011
- Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feedingInflammatory Bowel Diseases, 2010
- Inflammatory bowel disease in pregnancyBMJ, 2008
- Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conceptionAlimentary Pharmacology & Therapeutics, 2008
- Pregnancy before and after the diagnosis of inflammatory bowel diseases: Retrospective case–control studyJournal of Gastroenterology and Hepatology, 2007
- Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairsBritish Journal of Clinical Pharmacology, 2006
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- Infliximab treatment and pregnancy outcome in active Crohn's diseaseAmerican Journal of Gastroenterology, 2001